Amyloid β aggregation induces human brain microvascular endothelial cell death with abnormal actin organization

Yushiro Take1,2,3, Yusaku Chikai1, Keiya Shimamori1

  • 1Graduate School of Engineering, Muroran Institute of Technology, Hokkaido, 050-8585, Japan.

Insights

Amyloid beta (Aβ) aggregation damages brain blood vessels by anchoring endothelial cells, disrupting actin, and causing cell death. This study reveals key mechanisms behind cerebral amyloid angiopathy (CAA) fragility.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Cell Biology

Background:

  • Cerebral amyloid angiopathy (CAA) involves amyloid beta (Aβ) deposition in brain blood vessels, leading to fragility and hemorrhage.
  • The precise mechanisms driving vascular weakening in CAA remain unclear.
  • Aβ accumulation contributes to blood vessel occlusion, endothelial cell damage, and blood-brain barrier breakdown.

Purpose of the Study:

  • To investigate the real-time effects of amyloid beta (Aβ) on human primary brain microvascular endothelial cells (hBMECs).
  • To elucidate the molecular mechanisms underlying Aβ-induced vascular weakening in cerebral amyloid angiopathy (CAA).

Main Methods:

  • Utilized quantum dot nanoprobes for real-time observation of Aβ interactions with hBMECs.
  • Monitored Aβ aggregation, cell adhesion, motility, and cell death.
  • Quantified intracellular actin organization and changes in actin dots.

Main Results:

  • Observed Aβ aggregation around hBMECs, leading to cell coverage.
  • Found that Aβ aggregates anchored cells to the substrate, suppressed motility, and induced cell death.
  • Demonstrated that Aβ aggregation caused abnormal actin organization, significantly increasing intracellular actin dots.

Conclusions:

  • Aβ aggregation around vascular endothelial cells anchors them, disrupting normal function.
  • Abnormal actin organization and subsequent cell death are key mechanisms in Aβ-induced vascular fragility.
  • These findings provide insights into the pathogenesis of cerebral amyloid angiopathy (CAA).